Achieving high hemoglobin levels in patients with CKD anemia may confer no cardiovascular benefit and could even increase the risk of death and cardiac problems, according to two studies published in the New England Journal of Medicine (2006;355:2071-2084;2085-2098).
The recent publication of the CHOIR and CREATE studies in the New England Journal of Medicine questioning hemoglobin targets in dialysis patients have resulted in intense scrutiny of the relationship between Amgen, dialysis organizations, and physicians in the management of anemia.
Early use of phosphodiesterase inhibitors (PDEIs) following brachytherapy is associated with improved erectile function compared with late use of the drugs.
Duloxetine, a serotonin-noradrenalin reuptake inhibitor, may be an effective treatment for women with symptoms of overactive bladder (OAB). Duloxetine is marketed as Cymbalta for treating depression and diabetic peripheral neuropathy.
A mural featuring a sun-dappled lake, crimson and azure birds, lush flowers, and palm trees adorns one waiting room wall. In another, a comfy couch beckons; a cheery blaze crackles in the fireplace, and the aroma of hot coffee wafts from an adjacent kitchenette.
SAN DIEGO—Cuffed catheters for hemodialysis patients are associated with a 46% higher risk of septicemia or endocarditis compared with temporary catheters, according to a study of nearly 30,000 patients.
High preoperative C-reactive protein (CRP) levels are associated with worse survival in patients who undergo radical nephrectomy for localized renal cell carcinoma (RCC), according to investigators.
Selective serotonin-reuptake inhibitors (SSRIs) may inhibit sperm transport, resulting in impaired sperm motility and concentration in some men, researchers report.
Anemia in CKD patients is an important risk factor for progression to end-stage renal disease (ESRD).
Bone mineral density (BMD) may be reduced and parathyroid hormone (PTH) levels elevated in long-term renal transplant patients with good graft function, according to Swedish researchers.
